Tagged with

Daiichi Sankyo The general manager of Daiichi Sankyo Turkey discusses his affiliate’s expansion into a regional hub, current strategies for growth in the Turkish market, and the keys behind his affiliates multiple ‘great place to work’ awards.  In 2012, you had made it a goal to develop the Turkish affiliate into a regional…

Korea The following table shows how Seoul has risen through the ranks of cities around the world to become the most competitive city for clinical trials of pharma products in 2012.

As the following graph shows, Korea’s annual growth of pharma spending in real terms dropped ahead of the rest of the OECD.

Korea Compared to the OECD average growth rate for healthcare expenditure, Korea’s growth in expenditure on medicines has remained fairly flat, dropping to zero growth in 2010 for example.

Korea Rapid overview of South Korea’s top ten pharma companies within the larger Asian context. The largest South Korean company, Yuhan, ranks 35th in Asia, with a turnover of U$ 862 million in 2013. For more data and stories from South Korea, download our latest 2015 free report here

Daiichi Sankyo Daiichi Sankyo Thailand’s managing director explains the Thai subsidiary’s success under his leadership, Thailand’s untapped potential as a regional economic center in Southeast Asia and his company’s role in providing high quality products for consumers in Thailand.   What have been your greatest challenges and achievements as Managing Director? During my tenure in…

local The owner of an indigenous producer and contract manufacturer explains the plethora of new opportunities unfolding for customized industrial batch manufacturing and the impact that EU accession had on the local pharma manufacturing industry. How has domestic pharmaceutical production evolved in Romania? One of the landmark moments for Romanian pharmaceutical production…

Ferring The general manager of a speciality biopharma business challenges lawmakers to regard health spending not as a cost but as an investment and reveals how women’s healthcare and fertility treatment can become showcase examples in making Romanian healthcare sustainable. Back in 2011, when we asked you about Ferring’s priorities in…

Dr. Reddy's One of the new generation of country managers in Romania describes the importance of brand consciousness in the local market. In a highly intriguing and insightful interview, he outlines his ambitious strategy to buck the trend and focus his team’s energies on building brand loyalty and identity. Tell us about…

Astellas The country manager of a Japanese speciality pharma firm sheds light on his preparations for an eventual opening up of the national reimbursement list and speaks out about how Romania is fast becoming an outlier for organ transplants. How do you evaluate your tenure as country manager of Astellas Romania…

Merck The country manager of a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials describes the initiatives she has been putting in place to optimise and streamline the business during a period of belt tightening and increased regulatory forces. Of particular note are the innovative…

association The executive director of the German Chamber of Commerce in Romania explains why German companies are deeply embedded in the Romanian market, why the country should be seriously considered as an investment opportunity into Southeast Europe and how the local healthcare system is in need of extra funding, with public…